World Journal of Gastroenterology, 23 (36), 66506664
Some patients on lower doses for diabetes management report minimal to no increase in acid reflux symptoms
In this particular case, were providing additional access to beneficiaries who wouldnt otherwise be covered by Medicare for obesity indications, and so theres access to additional patients who could really benefit from these medications, and thats mutually beneficial for both the taxpayer, for those beneficiaries, as well as for the companies
Semaglutide primarily works by activating the GLP-1 receptor, which helps regulate appetite, satiety, food noise, gastric emptying, and blood sugar-related signaling
Once the mini-pump is inserted, there is no additional effort required by the user for the full three to six months
OW semaglutide significantly reduced mean HbA1c and body weight compared to OD empagliflozin, suggesting superior efficacy when added to metformin monotherapy